| Literature DB >> 30774928 |
Victoria Thörnqvist1,2, Roelinde Middelveld1,2, Hay Mar Wai1,2, Natalia Ballardini2,3, Evalill Nilsson4, Jennie Strömquist5, Staffan Ahlstedt1,2, Lennart Jan Nilsson5, Jennifer L P Protudjer1,2,6,7,8.
Abstract
BACKGROUND: Food allergy is negatively associated with health-related quality of life (HRQL). Although differences exist between parents and children, less is known about age-specific differences amongst children. As such, we aimed to identify if age, as well as other factors, are associated with food allergy-specific HRQL in an objectively defined population of children.Entities:
Keywords: Children; Food allergy; Food hypersensitivity; Health-related quality of life
Year: 2019 PMID: 30774928 PMCID: PMC6366088 DOI: 10.1186/s13601-019-0244-0
Source DB: PubMed Journal: Clin Transl Allergy ISSN: 2045-7022 Impact factor: 5.871
Linear regression analyses for children with specialist-diagnosed food allergy, by age group (n = 63)
| HRQL | Unadjusted | Model 1† | Model 2‡ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| B | 95% CI | B | 95% CI | B | 95% CI | ||||
| Overall | |||||||||
| 0–5 years | Ref | Ref | Ref | ||||||
| 6–12 years |
|
|
|
|
|
|
|
|
|
| FA | |||||||||
| 0–5 years | Ref | Ref | Ref | ||||||
| 6–12 years |
|
|
|
|
|
|
|
|
|
| EI | |||||||||
| 0–5 years | Ref | Ref | Ref | ||||||
| 6–12 years |
|
|
|
|
|
|
|
|
|
| SDL | |||||||||
| 0–5 years | Ref | Ref | Ref | ||||||
| 6–12 years |
|
|
| 0.39 | − 0.35–1.13 | 0.30 | 0.20 | − 0.58–0.97 | 0.61 |
95% CI 95th percent confidence interval, EAI epinephrine autoinjector, EI emotional impact, FA food anxiety, HRQL health-related quality of life, SDL social and dietary limitations
†Adjusted for symptom severity, EAI prescription and number of concomitant allergic diseases
‡Adjusted for symptom severity, EAI prescription, number of concomitant allergic diseases and region
Linear regression analyses for children with specialist-diagnosed food allergy, by proxies of severity (n = 59)
| HRQL | Unadjusted | Model 1† | Model 2‡ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| B | 95% CI | B | 95% CI | B | 95% CI | ||||
| A. Symptom severity | |||||||||
| Overall | |||||||||
| Less§ | Ref | Ref | Ref | ||||||
| More¶ |
|
|
| 0.46 | − 0.13–1.05 | 0.12 | 0.51 | − 0.09–1.10 | 0.09 |
| FA | |||||||||
| Less§ | Ref | Ref | Ref | ||||||
| More¶ |
|
|
| 0.28 | 0.33–0.89 | 0.37 | 0.27 | − 0.36–0.89 | 0.39 |
| EI | |||||||||
| Less§ | Ref | Ref | Ref | ||||||
| More¶ |
|
|
| 0.55 | − 0.07–1.16 | 0.81 | 0.59 | − 0.03–1.22 | 0.06 |
| SDL | |||||||||
| Less§ | Ref | Ref | Ref | ||||||
| More¶ |
|
|
| 0.48 | − 0.34–1.31 | 0.24 | 0.57 | − 0.25–1.39 | 0.17 |
| B. EAI prescription | |||||||||
| Overall | |||||||||
| No | Ref | Ref | Ref | ||||||
| Yes |
|
|
|
|
|
|
|
| |
| FA | |||||||||
| No | Ref | Ref | Ref | ||||||
| Yes |
|
|
|
|
|
|
|
|
|
| EI | |||||||||
| No | Ref | Ref | Ref | ||||||
| Yes |
|
|
|
|
|
| 0.55 | − 0.06–1.16 | 0.08 |
| SDL | |||||||||
| No | Ref | Ref | Ref | ||||||
| Yes |
|
|
| 0.53 | − 0.21–1.28 | 0.16 | 0.29 | − 0.51–1.10 | 0.47 |
| C. Number of concomitant allergic disease | |||||||||
| Overall | |||||||||
| 0–2 | Ref | Ref | Ref | ||||||
| 3 |
|
|
| 0.41 | − 0.13–0.95 | 0.13 | 0.42 | − 0.12–0.95 | 0.13 |
| FA | |||||||||
| 0–2 | Ref | Ref | Ref | ||||||
| 3 |
|
|
| 0.24 | − 0.32–0.79 | 0.40 | 0.23 | − 0.33–0.80 | 0.41 |
| EI | |||||||||
| 0–2 | Ref | Ref | Ref | ||||||
| 3 |
|
|
| 0.39 | − 0.18–0.95 | 0.17 | 0.39 | − 0.17–0.96 | 0.17 |
| SDL | |||||||||
| 0–2 | Ref | Ref | Ref | ||||||
| 3 |
|
|
| 0.63 | − 0.13–1.38 | 0.10 | 0.64 | − 0.11–1.38 | 0.09 |
95% CI 95th percent confidence interval, EAI epinephrine autoinjector, EI emotional impact, FA food anxiety, HRQL health-related quality of life, SDL social and dietary limitations
†Adjusted for age, EAI prescription and number of concomitant allergic diseases
‡Adjusted for age, EAI prescription, number of concomitant allergic diseases and region
§Less severe symptoms: skin, oral, gastroenteritis and/or rhinoconjunctivitis
¶More severe symptoms: respiratory and/or cardiovascular